Tirzepatide, a recently approved medication, is creating significant interest in the scientific community as a viable treatment for both type 2 diabetes and reducing body fat. This unique drug works by targeting two distinct receptors, GLP-1 and GIP, leading to improved glycemic management and significant weight reduction in research studies . Whil